News summary

Fight Aging! Newsletter, September 21st 2026

Source: Fight Aging! • Published: 20 Sept 2026, 11:08

Summarized by Masters of Longevity from Fight Aging!.

This newsletter presents a roundup of recent aging-research updates, framing studies on midlife hormonal intervention in mice and telomerase activity in hydra for readers curious about translational geroscience.

Fight Aging! Newsletter, September 21st 2026
Key Takeaways
  • Midlife ablation of the growth hormone receptor in mice produced an endocrine GH resistance signature and extended lifespan in both sexes.
  • Male mice with midlife Ghr ablation showed improved insulin sensitivity despite increased adiposity and preserved neuromuscular and bone health.
  • Hydra vulgaris expresses a telomerase catalytic subunit (hyTERT) in proliferative regions and shows sustained telomerase activity linked to negligible senescence.
Read the full article at Fight Aging!

Continue exploring

Recommended MoL Picks

MoL PickGrowth Hormone Receptor Deletion Extends Mouse LifespanStudy summary: researchers switched off the growth hormone receptor in middle-aged mice and followed survival and physical function.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickReducing Inflammation from Ageing Cells: What a Mouse Study FoundResearchers reduced the inflammatory signals released by cells that had stopped dividing. Older mice also improved on some strength and frailty tests. Whether this approach could help people remains unknown.